JP2009541437A5 - - Google Patents

Download PDF

Info

Publication number
JP2009541437A5
JP2009541437A5 JP2009517174A JP2009517174A JP2009541437A5 JP 2009541437 A5 JP2009541437 A5 JP 2009541437A5 JP 2009517174 A JP2009517174 A JP 2009517174A JP 2009517174 A JP2009517174 A JP 2009517174A JP 2009541437 A5 JP2009541437 A5 JP 2009541437A5
Authority
JP
Japan
Prior art keywords
pain
amino
hydroxymethyl
cancer
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009517174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009541437A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/056377 external-priority patent/WO2008000744A2/en
Publication of JP2009541437A publication Critical patent/JP2009541437A/ja
Publication of JP2009541437A5 publication Critical patent/JP2009541437A5/ja
Withdrawn legal-status Critical Current

Links

JP2009517174A 2006-06-27 2007-06-26 治療用化合物 Withdrawn JP2009541437A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0601397 2006-06-27
US83740206P 2006-08-11 2006-08-11
PCT/EP2007/056377 WO2008000744A2 (en) 2006-06-27 2007-06-26 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor

Publications (2)

Publication Number Publication Date
JP2009541437A JP2009541437A (ja) 2009-11-26
JP2009541437A5 true JP2009541437A5 (enExample) 2010-08-05

Family

ID=38573394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009517174A Withdrawn JP2009541437A (ja) 2006-06-27 2007-06-26 治療用化合物

Country Status (10)

Country Link
US (1) US7820811B2 (enExample)
EP (1) EP2081932A2 (enExample)
JP (1) JP2009541437A (enExample)
CN (1) CN101479268B (enExample)
AU (1) AU2007263727A1 (enExample)
BR (1) BRPI0713902A2 (enExample)
CA (1) CA2654371A1 (enExample)
NZ (1) NZ573307A (enExample)
RU (1) RU2009102536A (enExample)
WO (1) WO2008000744A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ573308A (en) * 2006-06-27 2012-02-24 Biovitrum Ab Publ Adenosine derivatives for the treatment of pain
WO2012048013A2 (en) * 2010-10-06 2012-04-12 Inhibitex, Inc. Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843066A (en) 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
US5968914A (en) 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
WO1991006556A1 (en) * 1989-10-24 1991-05-16 Gilead Sciences, Inc. 2' modified oligonucleotides
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
US5705491A (en) 1992-10-27 1998-01-06 Nippon Zoki Pharmaceutical Co., Ltd. Adenosine deaminase inhibitor
US5877180A (en) 1994-07-11 1999-03-02 University Of Virginia Patent Foundation Method for treating inflammatory diseases with A2a adenosine receptor agonists
ES2194320T3 (es) 1997-06-03 2003-11-16 Itochu Techno Chem Inc Sustancias naturales antivirales o antitumorales y uso de las mismas.
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
KR20050055630A (ko) 2002-06-28 2005-06-13 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305149D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
GB0305153D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds
GB0305150D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Use of therapeutic compounds
GB0328323D0 (en) 2003-12-05 2004-01-07 Cambridge Biotechnology Ltd Synthesis of 2-substituted adenosines
KR20070004792A (ko) 2004-03-05 2007-01-09 캠브리지 바이오테크놀로지 리미티드 아데노신 수용체 작용제
NZ573308A (en) 2006-06-27 2012-02-24 Biovitrum Ab Publ Adenosine derivatives for the treatment of pain

Similar Documents

Publication Publication Date Title
AU2020286299B2 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
KR102327464B1 (ko) 인플루엔자 rna 복제의 저해제로서의 4'-다이플루오로메틸 치환된 뉴클레오사이드 유도체
US6297232B1 (en) Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
JP2009541436A5 (enExample)
JP6475252B2 (ja) ヘテロアリール置換のニコチンアミド化合物
AP1372A (en) Purine derivatives.
US6713483B1 (en) [1,2,3]-triazolo[4,5-d] pyrimidine compounds
JP2005534684A5 (enExample)
CZ20023875A3 (cs) 2-Aminokarbonyl-9H-purinové deriváty
WO2008124085A2 (en) Methods of using combinations of mek and jak-2 inhibitors
CZ20021223A3 (cs) Purinové deriváty
JP2007507483A (ja) Ｈｉｖ及び炎症の治療のためのｃｃｒ５受容体拮抗活性を有するイミダゾピリジン置換トロパン誘導体
JP2007537272A5 (enExample)
RU2009102512A (ru) Терапевтические соединения
IL297041A (en) Inhibitors of human immunodeficiency virus replication
JP2009541438A5 (enExample)
EP3197457A1 (en) 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication
RU2009102531A (ru) Терапевтические соединения
JP7522414B2 (ja) Ｊａｋキナーゼ阻害剤、その調製および適用
RU2009102536A (ru) Терапевтические соединения
JPH05507267A (ja) カルボ―ヌクレオシド誘導体
EP3530738A1 (en) Tnf- -binding aptamer, and therapeutic use for same
US20080194635A1 (en) Crystalline Forms of Cis-5-Fluoro-N-[4-(2-Hydroxy-4-Methylbenzamido) Cyclohexyl]-2-(Tetrahydrothiopyran-4-Yloxy) Nicotinamide
TW202547514A (zh) 人類免疫不全病毒複製之抑制劑
HK1225617B (en) 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza rna replication